Paralytic Peptide for Use in Neuromuscular Therapy

John M Stewart; Bradley J Steeves; Karl Vernes

Paralytic Peptide for Use in Neuromuscular Therapy

John M Stewart (Creator), Bradley J Steeves (Creator), Karl Vernes (Creator)

School of Environmental & Rural Science

Research output: Patent

Abstract

The invention relates to a low molecular weight peptide (or suite of related peptides) isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent. This novel paralytic agent is useful as a neuromuscular blocker and analgesic or as an insecticide.

Original language	English
Patent number	US2008/0045458A1
Publication status	Published - 21 Feb 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

https://hdl.handle.net/1959.11/54848

Handle.net

Persistent link

Cite this

@misc{22479549110044d8bd7a282dd3850e08,

title = "Paralytic Peptide for Use in Neuromuscular Therapy",

abstract = "The invention relates to a low molecular weight peptide (or suite of related peptides) isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent. This novel paralytic agent is useful as a neuromuscular blocker and analgesic or as an insecticide.",

author = "Stewart, \{John M\} and Steeves, \{Bradley J\} and Karl Vernes",

note = "Assignee: BIOPROSPECTING NB INC., New Brunswick (CA) Appl. No.: 11/834,871; US2008/0045458A1",

year = "2008",

month = feb,

day = "21",

language = "English",

publisher = "United States Patent",

type = "Patent",

}

TY - PAT

T1 - Paralytic Peptide for Use in Neuromuscular Therapy

A2 - Stewart, John M

A2 - Steeves, Bradley J

A2 - Vernes, Karl

N1 - Assignee: BIOPROSPECTING NB INC., New Brunswick (CA) Appl. No.: 11/834,871

PY - 2008/2/21

Y1 - 2008/2/21

N2 - The invention relates to a low molecular weight peptide (or suite of related peptides) isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent. This novel paralytic agent is useful as a neuromuscular blocker and analgesic or as an insecticide.

AB - The invention relates to a low molecular weight peptide (or suite of related peptides) isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent. This novel paralytic agent is useful as a neuromuscular blocker and analgesic or as an insecticide.

UR - https://patents.google.com/patent/US20080045458

M3 - Patent

M1 - US2008/0045458A1

PB - United States Patent

ER -

Paralytic Peptide for Use in Neuromuscular Therapy

Abstract

UN SDGs

Access to Document

Handle.net

Fingerprint

Cite this